Skip to content

Hoda Lavasani

3 papers in the library · 11 citations · publishing 2017-2026

Papers

Sort Most recent Most cited

MDMA-induced CYP2D6 inhibition: concentration-dependent variability using dextromethorphan as a probe

Drug Metabolism and Personalized Therapy June 16, 2026 Faezeh Ahmadi, Hoda Lavasani, Mohammadhosein Keshvadi et al.

OBJECTIVES: Ecstasy is commonly abused due to entactogenic effects. Although our previous studies on isolated perfused rat model confirmed inhibition of CYP2D6 by MDMA, the time for enzyme recovery was different when mirtazapine and tramadol were used as substrates. Therefore, present study intended to investigate CYP2D6 inhibition by MDMA using dextromethorphan as a well-known probe. Two...

Inhibition of mirtazapine metabolism by Ecstasy (MDMA) in isolated perfused rat liver model.

Daru June 28, 2017 Sanaz Jamshidfar, Yalda H. Ardakani, Hoda Lavasani et al. 5 citations

Nowadays MDMA (3,4-methylendioxymethamphetamine), known as ecstasy, is widely abused among the youth because of euphoria induction in acute exposure. However, abusers are predisposed to depression in chronic consumption of this illicit compound. Mirtazapine (MRZ), an antidepressant agent, may be prescribed in MDMA-induced depression. MRZ is extensively metabolized in liver by CYP450 isoenzymes....

Evaluation of the Ecstasy influence on tramadol and its main metabolite plasma concentration in rats

Drug Metabolism and Personalized Therapy January 26, 2017 Bardia Jamali, Behjat Sheikholeslami, Yalda Hosseinzadeh Ardakani et al. 6 citations

AbstractBackground:Tramadol is prone to be abused alone, or in combination with 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy). It was reported that 95% of people with a history of substance abuse in the United States used tramadol in 2004. According to the WHO report in 2016, there was a growing number of tramadol abusers alone or in combination with psychoactive substances such as MDMA in...